233 related articles for article (PubMed ID: 20133804)
1. A role for FKBP52 in Tau protein function.
Chambraud B; Sardin E; Giustiniani J; Dounane O; Schumacher M; Goedert M; Baulieu EE
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2658-63. PubMed ID: 20133804
[TBL] [Abstract][Full Text] [Related]
2. Decrease of the immunophilin FKBP52 accumulation in human brains of Alzheimer's disease and FTDP-17.
Giustiniani J; Sineus M; Sardin E; Dounane O; Panchal M; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE
J Alzheimers Dis; 2012; 29(2):471-83. PubMed ID: 22233767
[TBL] [Abstract][Full Text] [Related]
3. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior.
Giustiniani J; Guillemeau K; Dounane O; Sardin E; Huvent I; Schmitt A; Hamdane M; Buée L; Landrieu I; Lippens G; Baulieu EE; Chambraud B
FASEB J; 2015 Aug; 29(8):3171-81. PubMed ID: 25888602
[TBL] [Abstract][Full Text] [Related]
4. Immunophilin FKBP52 induces Tau-P301L filamentous assembly in vitro and modulates its activity in a model of tauopathy.
Giustiniani J; Chambraud B; Sardin E; Dounane O; Guillemeau K; Nakatani H; Paquet D; Kamah A; Landrieu I; Lippens G; Baulieu EE; Tawk M
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4584-9. PubMed ID: 24623856
[TBL] [Abstract][Full Text] [Related]
5. Caspase-cleaved Tau-D(421) is colocalized with the immunophilin FKBP52 in the autophagy-endolysosomal system of Alzheimer's disease neurons.
Meduri G; Guillemeau K; Dounane O; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE; Giustiniani J
Neurobiol Aging; 2016 Oct; 46():124-37. PubMed ID: 27479154
[TBL] [Abstract][Full Text] [Related]
6. The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation.
Chambraud B; Belabes H; Fontaine-Lenoir V; Fellous A; Baulieu EE
FASEB J; 2007 Sep; 21(11):2787-97. PubMed ID: 17435176
[TBL] [Abstract][Full Text] [Related]
7. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
Criado-Marrero M; Gebru NT; Blazier DM; Gould LA; Baker JD; Beaulieu-Abdelahad D; Blair LJ
Acta Neuropathol Commun; 2021 Apr; 9(1):65. PubMed ID: 33832539
[TBL] [Abstract][Full Text] [Related]
8. Isomerization and Oligomerization of Truncated and Mutated Tau Forms by FKBP52 are Independent Processes.
Kamah A; Cantrelle FX; Huvent I; Giustiniani J; Guillemeau K; Byrne C; Jacquot Y; Landrieu I; Baulieu EE; Smet C; Chambraud B; Lippens G
J Mol Biol; 2016 Mar; 428(6):1080-1090. PubMed ID: 26903089
[TBL] [Abstract][Full Text] [Related]
9. FKBP52 in Neuronal Signaling and Neurodegenerative Diseases: A Microtubule Story.
Chambraud B; Byrne C; Meduri G; Baulieu EE; Giustiniani J
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163662
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of WO2011045166A1, Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction.
Zheng F; Zhang B; Sun Y; Qiu M; Su J
Expert Opin Ther Pat; 2015 Jul; 25(7):831-5. PubMed ID: 25945965
[TBL] [Abstract][Full Text] [Related]
11. Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth.
Quintá HR; Maschi D; Gomez-Sanchez C; Piwien-Pilipuk G; Galigniana MD
J Neurochem; 2010 Nov; 115(3):716-34. PubMed ID: 20796173
[TBL] [Abstract][Full Text] [Related]
12. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
13. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
14. Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability.
Esmaeli-Azad B; McCarty JH; Feinstein SC
J Cell Sci; 1994 Apr; 107 ( Pt 4)():869-79. PubMed ID: 8056843
[TBL] [Abstract][Full Text] [Related]
15. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
16. Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease.
Shahpasand K; Uemura I; Saito T; Asano T; Hata K; Shibata K; Toyoshima Y; Hasegawa M; Hisanaga S
J Neurosci; 2012 Feb; 32(7):2430-41. PubMed ID: 22396417
[TBL] [Abstract][Full Text] [Related]
17. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
Goedert M; Spillantini MG
Biochim Biophys Acta; 2000 Jul; 1502(1):110-21. PubMed ID: 10899436
[TBL] [Abstract][Full Text] [Related]
18. Mutations causing neurodegenerative tauopathies.
Goedert M; Jakes R
Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
[TBL] [Abstract][Full Text] [Related]
19. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Spillantini MG; Van Swieten JC; Goedert M
Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
[TBL] [Abstract][Full Text] [Related]
20. Digital quantification of neurite outgrowth and retraction by phase-contrast microscopy: A tau perspective.
Cook B; Proctor D; Bromberg R; LaPointe NE; Feinstein SC; Wilson L
Methods Cell Biol; 2017; 141():217-228. PubMed ID: 28882303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
